The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Elevance Health (NYSE:ELV) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...

Truist raised the firm’s price target on Elevance Health (ELV) to $510 from $480 and keeps a Buy rating on the shares as part of a broader ...

In its first quarter 2025 investor letter, GreensKeeper Asset Management emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company ...

Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are ...

Importantly, Elevance Health, Inc. (NYSE:ELV) does carry debt. But the more important question is: how much risk is that debt creating? Debt assists a business until the business has trouble ...

Shares of NYSE ELV opened at $417.77 on Wednesday. Elevance Health has a twelve month low of $362.21 and a twelve month high of $567.26. The company has a current ratio of 1.45, a quick ratio of 1 ...

In its fourth quarter 2024 investor letter, Hotchkis & Wiley Large Cap Fundamental Value Fund emphasized stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...